TipRanks on MSN
Senseonics resumed with a Hold at Stifel
Stifel resumed coverage of Senseonics (SENS) with a Hold rating and $9 price target The firm views its physician diligence “favorably” and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback